TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma

Background: There is no standard chemotherapy for refractory or relapsing malignant pleural mesothelioma (MPM). Our previous reports nevertheless indicated that a combination of an anthracycline (doxorubicin) and a lysine deacetylase inhibitor (valproic acid, VPA) synergize to induce the apoptosis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Staumont, Bernard, Jamakhani, Majeed, Costa, Chrisostome, Vandermeers, Fabian, Sriramareddy, Sathya Neelature, Redouté, Gaëlle, Mascaux, Céline, Delvenne, Philippe, Hubert, Pascale, Safari, Roghaiyeh, Willems, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352199/
https://www.ncbi.nlm.nih.gov/pubmed/32517259
http://dx.doi.org/10.3390/cancers12061484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352199/
https://www.ncbi.nlm.nih.gov/pubmed/32517259
http://dx.doi.org/10.3390/cancers12061484

Ejemplares similares